What is the electrophysiology of short‑coupled premature ventricular contractions?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 11, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Electrophysiology of Short-Coupled PVCs

Short-coupled PVCs arise predominantly from the Purkinje system in either ventricle, characterized by ultra-short coupling intervals (<350 ms, often <300 ms), and represent a distinct electrophysiological substrate capable of triggering polymorphic ventricular tachycardia and ventricular fibrillation through a mechanism distinct from typical PVCs 1, 2.

Origin and Anatomical Substrate

The electrophysiological origin is highly specific:

  • Purkinje system dominance: Short-coupled PVCs most commonly originate from the His-Purkinje network in either the right or left ventricle, rather than from ventricular myocardium 1
  • Specific anatomical sites include:
    • Left anterior fascicle 3
    • Right ventricular moderator band 4
    • Ventricular outflow tracts (less commonly) 1

Defining Electrophysiological Characteristics

The critical electrophysiological parameters that define this entity:

  • Coupling interval: <350 ms is the diagnostic threshold 2, with mean intervals around 274 ± 32 ms in documented cases 2
  • Ultra-short coupling: Intervals <300 ms represent particularly high-risk markers requiring mechanism-specific therapy 5
  • Consistent QRS morphology: The triggering PVCs typically demonstrate a reproducible morphology, reflecting a fixed anatomical origin 1

Arrhythmogenic Mechanism

The electrophysiological mechanism differs fundamentally from other PVC-induced arrhythmias:

  • Direct VF initiation: These PVCs trigger polymorphic VT/VF through their extremely short coupling interval, landing during the vulnerable period of ventricular repolarization 1, 2
  • Electrical storm propensity: 21% of patients experience electrical storm, significantly higher than other unexplained cardiac arrest survivors 2
  • High recurrence risk: 87% of patients in one series experienced VF episodes in the preceding year before ablation 1

Critical Clinical Pitfall

The ultra-short coupling interval (<300 ms) serves as the pivotal electrophysiological marker that should trigger a shift from standard sodium channel blockade (lidocaine) to calcium channel antagonism (verapamil) or other mechanism-specific therapies 5. Standard antiarrhythmic approaches targeting typical PVCs are often ineffective because the Purkinje origin and coupling characteristics require different pharmacological targeting 5, 3.

Tissue-Level Electrophysiology

The Purkinje origin creates unique electrophysiological vulnerabilities:

  • Source-sink mismatch: Small clusters of pathological Purkinje cells can overcome the electrical sink effect of surrounding myocardium when structurally or functionally isolated 6
  • Tissue heterogeneity: Regions of weak electrical coupling can electrically isolate these Purkinje foci, allowing them to reach the "critical mass" needed to initiate arrhythmia 6

Diagnostic Documentation Requirements

Most cases (79%) require documented ventricular fibrillation during follow-up for definitive diagnosis, as the short-coupled trigger must be captured on monitoring to distinguish this from other idiopathic VF phenotypes 2. The coupling interval measurement from the preceding QRS complex to the PVC is the essential electrophysiological parameter for diagnosis.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.